Aveir DR Real-World Evidence Post-Approval Study
NCT: NCT05935007 · RECRUITING
Brief Summary
The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.
Frequently Asked Questions
What is Aveir DR Real-World Evidence Post-Approval Study?
Aveir DR Real-World Evidence Post-Approval Study is a clinical trial registered under NCT05935007. Current status: RECRUITING.
What is the status of NCT05935007?
The current status of NCT05935007 (Aveir DR Real-World Evidence Post-Approval Study) is: RECRUITING.
When did Aveir DR Real-World Evidence Post-Approval Study start?
Aveir DR Real-World Evidence Post-Approval Study started on 2023-10-31.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.